Bio-Rad Laboratories Inc. (BIO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Bio-Rad Laboratories Inc., updated every trading day.
Industrials · Biotechnology: Laboratory Analytical Instruments
Price
$385.12
+1.08% today
Market cap
$10.2B
Overall quality
56/100
Kronos AI 30-day
−9.7%
0 of 8 simulated paths end higher
Bio-Rad Laboratories Inc. (BIO) is a Industrials company in Biotechnology: Laboratory Analytical Instruments, worth $10.2B. It trades at $385.12, up 1.08% today, at 37.6 times earnings. Its overall quality score is 56 out of 100, ranked against the whole US market. 2 analysts' average target of $360.00 implies −6.5% from today's price. Kronos AI's 30-day forecast is −9.7% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $360.00 |
| Low – high | $330.00 – $390.00 |
| Analysts | 2 |
| Upside to average | −6.5% |
Kronos AI 30-day forecast
| Expected close | $344.16 (−9.7%) |
| Likely range | −16.5% … −3.8% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 60 |
| Solvency | 64 |
| Growth | 43 |
| Overall | 56 |
| P/E | 37.6 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Laboratory Analytical Instruments
For information only, not investment advice. Prices updated: 2026-10-29.